Latest filing published 24 Oct 2024 for Creo Medical Group plc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -44.4%Entry £0.20 · Close at T+365 £0.11
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Rachel Rees: trading record in brief
This profile gathers the share dealings of Rachel Rees in Creo Medical Group plc. Activity is concentrated on a single trading day, 24 October 2024, with 2 filings.
Every open-market trade on record is a purchase: 2 purchases, and no sale. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 24 October 2024: an open-market purchase, in Creo Medical Group plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rachel Rees
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0London Stock ExchangeRNS:5402721-2Canonical exit: 22 Jan 2025 (T+90)
- 0London Stock ExchangeRNS:5402651-2Canonical exit: 22 Jan 2025 (T+90)
2 of 2 declarations